The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Concerted Action Polyposis Prevention.
Burn
J
J
CAPP Study Coordinating Centre, Dept Human Genetics, University of Newcastle upon Tyne, U.K.
Chapman
P D
PD
Mathers
J
J
Bertario
L
L
Bishop
D T
DT
Bülow
S
S
Cummings
J
J
Phillips
R
R
Vasen
H
H
D011125:Adenomatous Polyposis Coli / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002985:Clinical Protocols; D003113:Colonoscopy; D004040:Dietary Carbohydrates / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D013213:Starch / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004040:Dietary Carbohydrates; D013213:Starch; D001241:Aspirin